The FDA announced last week that it had approved the Immediate Post-Concussion Assessment and Cognitive Testing (ImPACT) and ImPACT Pediatric medical apps. The pair are the first medical devices permitted for marketing that are intended to assess cognitive function following a possible concussion. The first is designed for patients between 12 to 59 years old and runs on a laptop. The other, ImPACT Pediatric, is for kids younger than 12 years old and runs on an iPad. It’s designed to perform a clinician-guided test of cognitive skills like word memory, reaction time and word recognition to aid in assessment of head injuries. Tests take about 25 minutes and results can be compared to an age-matched cohort from the company’s large database of “normal” patients or to pre-injury baseline test taken by the patient. The FDA emphasized that the apps should not be used as the only diagnostic tool.
Read more via MedPage Today here.